Abstract
Aim:
The 3-azabicyclo(3,3,1)nonanyl-9-α-yl-α -cyclopentyl-α -phenyl-α -glycolate (DM-phencynonate hydrochloride, DMCPG) is a demethylated metabolite of 3- methyl-3-azabicyclo(3,3,1)nonanyl-9-α-yl-α-cyclopentyl-α-phenyl-α-glycolate (phencynonate hydrochloride, CPG). (±)DMCPG had one chiral center and two enantiomers [R(-) and S(+)DMCPG]. Here we carried out a comparative study of the pharmacological profiles of these optical isomers.
Methods:
Affinity and relative efficacy were tested using a radioligand-binding assay with muscarinic acetylcholine receptors from the rat cerebral cortex. Pharmacological activity was assessed in three individual experiments: (1) potentiating the effect of a subthreshold hypnotic dose of sodium pentobarbital; (2) inhibiting oxotremorine- induced salivation; and (3) inhibiting the contractile response to carbachol.
Results:
In the competitive binding assay, R(−)DMCPG (Ki=763.75 nmol/L) was 4- and 2-fold more potent than (±)DMCPG (Ki=3186 nmol/L) and S(+)DMCPG (Ki=1699 nmol/L) in inhibiting the binding of [3H]QNB. The R(−) and S (+) configurations showed positive cooperation (nH>1) with the muscarinic receptor, whereas (±)DMCPG had a negative cooperation (nH<1) relationship with the muscarinic receptor in a radio-binding assay. Both the R(−) and S(+) configurations could potentiate the effect of sub-threshold hypnotic dose of sodium pentobarbital in a dose-dependent manner (the ED50 values were 2.53 and 18.65 mg/kg, respectively), but (±)DMCPG did not display significant central depressant effects at doses from 10 to 29.15 mg/kg (P>0.05). (±)DMCPG and its optical isomers suppressed the guinea pig ileum contractile response to carbachol. The IC50 values were 7.78×10−9, 1.88×10−7, and 1.03×10−7 nmol/L, respectively. In the anti-salivation study, (±)DMCPG and its enantiomers depressed oxotremorine- induced salivation in a dose-dependent manner, and the order of potency was R(-)DMCPG (ED50=0.44 mg/kg)>(±)DMCPG (ED50=2.88 mg/kg)>S(+)DMCPG (ED50=5.05 mg/kg).
Conclusion:
(±)DMCPG and its optical isomers have differences in their pharmacological potencies as anticholinergic agents, and the R(−) configuration is more active than the S(+) configuration.
Similar content being viewed by others
Article PDF
References
Dai JG, Liu CG, Yu LS, Yang AZ, Jia HB, Wang, KN . Antimotion sickness effect of phencynonate hydrochloride in man. Chin J Aerospace Med 1997; 8: 10–4.
Deng YJ, Zhang YM . Study on the efficacy of phencynonate hydrochloride tablets in prevention of motion sickness. Chin J New Drugs 2001; 10: 453–4.
Wang LY, Zheng JQ, Zhong BH, Ruan JX, Liu KL . Pharmacological profiles of anticholinergic agents, phencynonate hydrochloride and its optical isomers. Acta Pharmacol Sin 2005; 26: 613–40.
Yamamura HI, Snyder SH . Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 1974; 71: 1725–9.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ . Protein measurement with the Folinphenol reagent. J Biol Chem 1951; 193: 265–75.
Cheng Y, Prusoff WH . Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099–108.
Nathanson NM . Molecular properties of the muscarinic acetyl-choline receptor. Annu Rev Neurosci 1987; 10: 195–236.
Hulme EC, Berrie CP, Birdsall NJM, Burgen ASV . Two populations of binding sites for muscarinic receptor antagonists in the rat heart. Eur J Pharmacol 1981; 73: 137–42.
Stockton J, Birdsall NJM, Burgen ASV, Hulme EC . Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 1983; 23: 551–7.
Ellis J . Allosteric binding sites on muscarinic receptors. Drug Dev Res 1997; 40: 193–204.
Christopoulos A, Lanzafame A, Mitchelson F . Allosteric interactions at muscarinic cholinoceptors. Clin Exp Pharmacol Physiol 1998; 25: 185–94.
Lee NH, El-Fakahany EE . Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 1991; 42: 199–205.
Holzgrabe U, Mohr K . Allosteric modulators of ligand binding to muscarinic acetylcholine receptors. Drug Res Today 1998; 3: 214–22.
Christopoulos A, Lanzafame A, Mitchelson F . Allosteric interactions at muscarinic cholinoceptors. Clin Exp Pharmacol Physiol 1998; 25: 185–94.
Proŝka J, Tuèek S Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 1994; 45: 709–17.
Wess J . Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci 2003; 24: 414–20.
Volpicelli LA, Levey AI . Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004; 145: 59–66.
Nakamura T, Matsui M, Uchida K, Futatsugi A, Kusakawa S, Matsumoto N, et al. M (3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol 2004; 558: 561–75.
Gautam D, Heard TS, Cui Y, Miller G, Bloodworth L, Wess J . Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. Mol Pharmacol 2004; 66: 260–7.
Ehlert FJ, Thomas EA . Functional role of M2 muscarinic receptors in the guinea pig ileum. Life Sci 1995; 56: 965–71.
Honda K, Takano Y, Kamiya H . Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea pig ileum. Jpn J Pharmacol 1993; 62: 43–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Major Programs Project, National Natural Science Foundation of China (No 203900508).
Rights and permissions
About this article
Cite this article
Wang, Ly., Zheng, Jq., Wang, Y. et al. Comparative study on pharmacological effects of DM-phencynonate hydrochloride and its optical isomers. Acta Pharmacol Sin 26, 1187–1192 (2005). https://doi.org/10.1111/j.1745-7254.2005.00183.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00183.x